Shorts

1:03
Why Bone Health Is Crucial in Prostate Cancer Treatment
8 months ago
by
Daniel P. Petrylak, MD

0:38
Why PSMA PET Is the New Gold Standard for Prostate Cancer
8 months ago
by
Scott Tagawa, MD, MS, FACP, FASCO

0:35
Impressive Durability in New Cancer Combo Therapy
8 months ago

0:28
Dr Hoehn on a More Equitable Approach to Clinical Trials
8 months ago
by
Richard Hoehn, MD

0:40
A Breakthrough in Renal Cell Carcinoma Treatment
8 months ago
by
Yousef Zakharia, MD

0:55
How ctDNA and Genomics Are Changing Modern Oncology
8 months ago
by
Kevin Kalinsky, MD, MS

0:24
ctDNA: The Future of Detecting Cancer Recurrence
8 months ago
by
Estelamari Rodriguez, MD, MPH

0:56
T-Cell Engagers Look Promising in Prostate Cancer
8 months ago
by
Sandy Srinivas, MD

0:17
Turning “Negative” PDAC Trials Into Future Breakthroughs
8 months ago
by
Dimitrios Sidiropoulos, PhD

1:00
The Flaw in Current Prostate Cancer Biomarkers
8 months ago
by
Michael S. Leapman, MD, MHS

0:37
Understanding Bone Protective Agents
8 months ago
by
David R. Wise, MD, PhD

1:14
Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
8 months ago
by
Joshua Reuss, MD

0:30
The “Donut” Pattern of Clinical Trial Enrollment
8 months ago
by
Richard Hoehn, MD

0:46
Strategies for Anemia Management in Myelofibrosis
8 months ago
by
Raajit Rampal, MD, PhD

0:31
Financial Barriers Outweigh Race in Clinical Trial Enrollment
8 months ago
by
Richard Hoehn, MD

0:39
Managing Anemia and Transfusion Access Challenges
8 months ago
by
Raajit Rampal, MD, PhD

0:31
Predicting Cancer Outcomes with ctDNA Status in Bladder Cancer
8 months ago
by
Pooja Ghatalia, MD

0:39
PIM Inhibitor Shows Promise in High-Risk Myelofibrosis
8 months ago
by
Firas El Chaer, MD

0:24
More Than a Marker: Behind the Aggressive Nature of CD25+ Leukemias
8 months ago
by
Markus Müschen, MD, PhD

0:32
What’s Needed to Bring Clinical Trials to the Patient
8 months ago
by
Jason Hammonds

1:19
Can GLP-1 Agonists Help Treat Rare Cancers?
8 months ago
by
Erica Pimenta, MD, PhD

0:38
Initial Assessments in Metastatic RCC
8 months ago
by
David Braun, MD, PhD

0:35
The Future of Oncology Innovation is Moving to the Community
8 months ago
by
Jason Hammonds

0:36
Medicaid Expansion Saves Lives in Breast Cancer
8 months ago
by
Oluwasegun Akinyemi, MD, PhD

1:06
Understanding Co-Mutations and Real-Time ctDNA Monitoring in Lung Cancer
9 months ago
by
Estelamari Rodriguez, MD, MPH

0:32
Developing Novel Alpha-Emitting Agents in Prostate Cancer
9 months ago
by
Fred Saad, MD, FRCS

0:33
The Silent Crisis: Why Oncologists are Burning Out
9 months ago
by
Pallav K. Mehta, MD(+1 more)

0:38
The Future of Hybrid Healthcare
9 months ago
by
Pallav K. Mehta, MD(+1 more)

0:31
The Most 'Ripe' Areas for AI in Healthcare Right Now
9 months ago
by
Pallav K. Mehta, MD(+1 more)

0:33
The Challenge Isn't the Medicine—It's the Operations
9 months ago
by
Jason Hammonds
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
